Bafna Pharmaceuticals Limited (BOM:532989)
India · Delayed Price · Currency is INR 247.00
+4.80 (1.98%)
At close: Aug 21, 2026
Bafna Pharmaceuticals Market Cap
Bafna Pharmaceuticals has a market cap or net worth of 5.74 billion as of August 21, 2026. Its market cap has increased by 133.84% in one year.
Market Cap
5.74B
Enterprise Value
6.09B
Revenue
1.43B
Ranking
n/a
PE Ratio
73.66
Stock Price
247.00
ChartMarket Cap Chart
Since March 2, 2020, Bafna Pharmaceuticals's market cap has increased from 10.88M to 5.74B, an increase of 52,606.51%. That is a compound annual growth rate of 163.29%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 21, 2026 | 5.74B | 60.86% |
| Dec 31, 2025 | 3.57B | 91.03% |
| Dec 31, 2024 | 1.87B | -14.24% |
| Dec 29, 2023 | 2.18B | -8.68% |
| Dec 30, 2022 | 2.38B | -33.96% |
| Dec 31, 2021 | 3.61B | -10.71% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Mar 2, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Wanbury | 9.40B |
| Bharat Parenterals | 9.23B |
| Sudarshan Pharma Industries | 8.93B |
| Hexagon Nutrition | 8.48B |
| Anuh Pharma | 7.64B |
| ZIM Laboratories | 6.50B |
| Kilitch Drugs (India) | 5.58B |
| Albert David | 4.77B |